Dr. Jason Paul Guthrie, MD

Dr. Guthrie practices at Springfield Clinic Physical Therapy - Springfield Clinic 1st - 800 Building in Springfield, Illinois.

Dr. Guthrie's NPI, 1437299682, was assigned on February 7, 2007. Dr. Guthrie holds Illinois license 036114747.

Dr. Guthrie's primary practice is Springfield Clinic Physical Therapy - Springfield Clinic 1st - 800 Building, at 800 N 1st St, Springfield, IL 62702. The practice phone is (217) 528-7541.

Dr. Guthrie's primary practice is Springfield Clinic Physical Therapy - Springfield Clinic 1st - 800 Building in Springfield, Illinois. Dr. Guthrie is also affiliated with Springfield Memorial Hospital. The medical group on file is Springfield Clinic. Dmand AI also links Dr. Guthrie to 4 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Guthrie's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guthrie practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Guthrie's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Guthrie is licensed in Illinois.

CMS data shows 57,468 Medicare services from Dr. Guthrie across 28 procedure codes in 2024, for 504 Medicare patients. Medicare paid $810,497 for them. Every service was in an office.

CMS counts 504 Medicare patients who saw Dr. Guthrie in 2024. The largest group is 65 to 74, with 264 patients. 75% of them have high blood pressure, and 73% have arthritis. 14% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guthrie's median patient age at 66, with 72% women.

In 2024, Dr. Guthrie wrote 3,364 Medicare Part D claims for 453 patients. 81% of them were for generic drugs. CMS names the drug for 3,246 of them, across 31 drugs with 11 or more claims each, at $3,554,308 in total drug cost. In 2023, CMS named 2,839 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Guthrie for performance year 2024, reported through an alternative payment model (APM). Dr. Guthrie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Guthrie in 2013. Dr. Guthrie's most frequent co-authors are John D. Carter, MD, Aasim Rehman, MD and Vanessa Coral Osting, DO, MPH.

Dmand AI links Dr. Guthrie to 1 clinical trial. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases.

CMS Open Payments shows 1,237 general payments to Dr. Guthrie from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Abbvie Inc. paid the most, $138,107. It also lists 1 research payment totaling $180 in 2018.